Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MediXall (MDXL) Return on Capital Employed (2019 - 2024)

MediXall's Return on Capital Employed history spans 5 years, with the latest figure at 0.61% for Q3 2024.

  • For Q3 2024, Return on Capital Employed fell 33.0% year-over-year to 0.61%; the TTM value through Sep 2024 reached 0.61%, down 33.0%, while the annual FY2023 figure was 0.74%, 117.0% up from the prior year.
  • Return on Capital Employed reached 0.61% in Q3 2024 per MDXL's latest filing, up from 0.45% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 128.22% in Q1 2022 to a low of 84.36% in Q4 2021.
  • Average Return on Capital Employed over 4 years is 10.02%, with a median of 0.94% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 13633bps in 2022, then plummeted -12689bps in 2023.
  • A 4-year view of Return on Capital Employed shows it stood at 84.36% in 2021, then soared by 102bps to 2.01% in 2022, then tumbled by -64bps to 0.72% in 2023, then dropped by -15bps to 0.61% in 2024.
  • Per Business Quant, the three most recent readings for MDXL's Return on Capital Employed are 0.61% (Q3 2024), 0.45% (Q2 2024), and 0.55% (Q1 2024).